AzTrials
AzTrials

Spastic Diplegic Cerebral PalsyNCT07829796

Effects of Transcranial Direct Current Stimulation Combined With Virtual Reality on Gait and Self-Esteem in Children With Spastic Cerebral Palsy

A study testing Active Transcranial Direct Current Stimulation, Virtual Reality Rehabilitation and Conventional Physical Therapy in people with Spastic Diplegic Cerebral Palsy, run by Riphah International University at 2 sites in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Cerebral palsy can affect walking ability, muscle control, functional mobility, and psychosocial well-being in children. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that may support motor learning, while virtual reality (VR) rehabilitation provides interactive… Read more about this study

Who is it for?
Ages 8 to 16 years
Conditions the study is for
Spastic Diplegic Cerebral Palsy
What is being tested?
Active Transcranial Direct Current Stimulation, Virtual Reality Rehabilitation and Conventional Physical Therapy
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
42 participants
Where
2 sitesPakistan
Study dates
15 Sep 2026to 28 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosed with spastic cerebral palsy (spastic diplegia). Age 8-16 years. Gross Motor Function Classification System (GMFCS) levels I-III. Presence of mild to moderate lower-limb spasticity, defined as a Modified Tardieu Scale (MTS) score between 1 and 3 in at least one major lower-limb muscle group, such as the gastrocnemius, hamstrings, or hip adductors.
  • Able to understand and follow verbal instructions. Parent or guardian provides informed consent and the child provides assent.

Who cannot join

  • History of seizures or epilepsy. Implanted metal or electronic devices, such as a pacemaker. Severe cognitive impairment that prevents comprehension of study tasks. Skin allergies, lesions, or other conditions affecting the electrode application sites.
  • Current use of antispasticity medication that could directly influence spasticity outcomes.
  • Botulinum toxin injection within the previous 3 months. Recent orthopedic surgery or change in medication regimen within the previous 5 days.
  • Concurrent participation in alternative or adjunct therapies outside the study protocol.
  • Refusal to participate or withdrawal of consent/assent.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

HASSAN R RAUF, MS PEDIATRIC PHYSICAL THERAPY contact

+923161504297

hassanrauf507@gmail.com

Pakistan2 sites, 2 recruiting
  • Al-Farabi Special Education Centre for Physically Handicapped

    Islamabad, 44000

    hassan rauf, MS PEDIATRIC PHYSICAL THERAPY, +923161504297, hassanrauf507@gmail.com

    Recruiting
  • Sedum School of Rehabilitation

    Islamabad, 44000

    hassan rauf, MS PEDIATRIC PHYSICAL THERAPY, +923161504297, hassanrauf507@gmail.com

    Recruiting

Other trials in Pakistan

About this study

Official title: Effects of Transcranial Direct Current Stimulation in Addition to Virtual Reality on Gait and Self-Esteem in Children With Spastic Cerebral Palsy: A Randomized Controlled Trial

Cerebral palsy can affect walking ability, muscle control, functional mobility, and psychosocial well-being in children. Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that may support motor learning, while virtual reality (VR) rehabilitation provides interactive, repetitive, and task-specific motor training.

This randomized controlled trial will investigate whether active tDCS combined with VR rehabilitation provides additional benefits compared with sham tDCS combined with the same VR rehabilitation and conventional physical therapy in children with spastic cerebral palsy.

Read more

A total of 42 children aged 8 to 16 years with spastic diplegic cerebral palsy and Gross Motor Function Classification System (GMFCS) levels I-III will be randomly assigned in a 1:1:1 ratio to one of three groups: active tDCS plus VR, sham tDCS plus VR, or conventional physical therapy. Each group will receive 18 treatment sessions over six weeks, with three sessions per week.

Outcomes will be assessed before treatment, after nine sessions, and after 18 sessions. The primary outcomes will be gait performance measured using the 10-Meter Walk Test and self-esteem measured using the Rosenberg Self-Esteem Scale. Secondary outcomes will evaluate spasticity, gross motor function, functional mobility, and functional independence.

Read the detailed description

This study is a three-arm, parallel-group, randomized controlled trial designed to evaluate the effects of active transcranial direct current stimulation (tDCS) combined with virtual reality (VR) rehabilitation in children with spastic cerebral palsy. The study will compare active tDCS plus VR with sham tDCS plus an identical VR protocol and with conventional physical therapy.

Forty-two children with spastic diplegic cerebral palsy, aged 8-16 years and classified within Gross Motor Function Classification System (GMFCS) levels I-III, will be enrolled. Eligible participants will be randomly allocated in a 1:1:1 ratio, with 14 participants assigned to each treatment group. Outcome assessment will be performed by an assessor blinded to treatment allocation.

Participants in all three groups will complete 18 treatment sessions over six weeks at a frequency of three sessions per week. The active tDCS plus VR group will receive low-intensity tDCS at 1 mA for 20 minutes per session in combination with a structured VR-based rehabilitation programme. The VR programme will include progressively challenging activities directed toward postural control, balance, coordination, gait-related activity, and cognitive-motor integration.

Participants in the sham tDCS plus VR group will undergo the same electrode setup and VR rehabilitation programme. Sham stimulation will be delivered briefly at the beginning of the session to reproduce the initial sensations of stimulation without providing continued active cortical stimulation. Participants allocated to conventional physical therapy will receive a structured rehabilitation programme incorporating stretching, lower-limb strengthening, balance training, gait training, functional mobility exercises, and progressive task-specific practice.

Assessments will be conducted at baseline before the intervention (S0), after nine treatment sessions at the midpoint of the programme (S9), and following completion of 18 treatment sessions (S18).

The co-primary outcomes will be gait performance, assessed using the 10-Meter Walk Test, and self-esteem, assessed using the child version of the Rosenberg Self-Esteem Scale. Secondary outcome domains will include spasticity assessed using the Modified Tardieu Scale, gross motor function assessed using the Gross Motor Function Measure-88, functional mobility assessed using the Functional Mobility Scale, and functional independence assessed using the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT).

The study is intended to determine whether active tDCS provides an additional therapeutic effect when combined with VR rehabilitation beyond the effects associated with VR training and sham stimulation, while also comparing the technology-assisted intervention with conventional physical therapy.

Being tested
Active Transcranial Direct Current Stimulation, Sham Transcranial Direct Current Stimulation, Virtual Reality Rehabilitation, Conventional Physical Therapy
Keywords
Spastic Cerebral Palsy, Spastic Diplegia, Transcranial Direct Current Stimulation, Virtual Reality, VR Rehabilitation, Walking Speed, Motor Function, Gross Motor Function
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active Transcranial Direct Current StimulationDevice

    Also called Active tDCS

    Active transcranial direct current stimulation will be delivered using saline-soaked sponge electrodes at an intensity of 1 mA for 20 minutes per session. Stimulation will be administered three times per week for six weeks, for a total of 18 sessions, concurrently with virtual reality rehabilitation. The stimulation montage will target the lower-limb motor cortical region with a supraorbital reference electrode.

  • Sham Transcranial Direct Current StimulationDevice

    Also called Sham tDCS

    Sham transcranial direct current stimulation will use the same electrode montage and setup as the active condition. Active current will be delivered only during the initial 30 seconds to reproduce the early sensory experience of stimulation, after which stimulation will be discontinued while the electrodes remain in place. Sham tDCS will be combined with the same virtual reality rehabilitation protocol as the active tDCS group.

  • Virtual Reality RehabilitationBehavioural

    Also called Xbox Kinect-Based Virtual Reality Therapy

    Virtual reality rehabilitation will be delivered using a Microsoft Xbox console with Kinect motion tracking. The program will include progressive whole-body, balance, gait-related, coordination, navigation, and dual-task activities using Kinect Adventures. Training will progress through familiarization, cognitive-motor integration, and challenge/functional integration phases over six weeks. VR will be provided in both the active and sham tDCS groups for 18 sessions.

  • Conventional Physical TherapyBehavioural

    Also called CPT

    Conventional physical therapy will be delivered for 30 minutes per session, three sessions per week for six weeks, for a total of 18 sessions. Treatment will progress from lower-limb stretching, supported balance and weight shifting to strengthening, motor-control exercises, gait initiation, overground gait training, obstacle negotiation, and functional mobility activities. Exercise difficulty and therapist support will be progressed according to participant tolerance and functional ability.

Study groups in NCT07829796
Study groupRoleWhat they receive
Experimental: Active tDCS + Virtual RealityExperimentalParticipants will receive active transcranial direct current stimulation at 1 mA for 20 minutes combined with virtual reality rehabilitation, three sessions per week for six weeks, for a total of 18 sessions.
Receives: Device: Active Transcranial Direct Current Stimulation; Behavioral: Virtual Reality Rehabilitation
Sham Comparator: Sham tDCS + Virtual RealitySham comparatorParticipants will receive sham transcranial direct current stimulation using the same electrode setup, with brief initial stimulation to mimic active tDCS, combined with the same virtual reality rehabilitation protocol, three sessions per week for six weeks.
Receives: Device: Sham Transcranial Direct Current Stimulation; Behavioral: Virtual Reality Rehabilitation
Active Comparator: Conventional Physical TherapyActive comparatorParticipants will receive conventional physical therapy including stretching, strengthening, balance training, gait training, and functional mobility exercises, three sessions per week for six weeks.
Receives: Behavioral: Conventional Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 10-Meter Walk Test Self-Selected Walking Velocity

    Gait performance will be assessed using the 10-Meter Walk Test at a self-selected walking pace. Walking velocity will be expressed in meters per second (m/s), with higher values indicating faster walking performance. The measure will be collected at baseline, mid-intervention, and post-intervention.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  2. Child Rosenberg Self-Esteem Scale Total Score

    Global self-esteem will be assessed using the Child Rosenberg Self-Esteem Scale. The scale contains 10 items and produces a total score ranging from 0 to 30, with higher scores indicating greater self-esteem. The total score will be assessed at baseline, mid-intervention, and post-intervention.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

Secondary outcomes (7)
  1. Modified Tardieu Scale

    Spasticity will be assessed using the Modified Tardieu Scale in the clinically affected lower-limb muscle groups. The assessment will include the quality of muscle reaction and the angles of muscle reaction (R1) and passive range of motion (R2). The dynamic component of spasticity will be calculated as R2 minus R1, expressed in degrees.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  2. GMFM-88

    Gross motor function will be assessed using the Gross Motor Function Measure-88 (GMFM-88). The instrument evaluates five dimensions: lying and rolling, sitting, crawling and kneeling, standing, and walking/running/jumping. Dimension and total scores will be expressed as percentages, with higher scores indicating better gross motor function.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  3. Functional Mobility Scale - 5 m, 50 m, and 500 m

    Functional mobility will be assessed using the Functional Mobility Scale at 5-meter, 50-meter, and 500-meter distances, representing mobility in home, school, and community environments. Each distance is rated on a 1-to-6 scale according to the level of assistance or mobility device required, with higher scores indicating greater functional mobility.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  4. Pediatric Evaluation of Disability Inventory-Computer Adaptive Test Daily Activities Domain Scaled Score

    Functional performance in daily activities will be assessed using the Daily Activities domain of the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). The domain is reported as a scaled score ranging from 20 to 80. Higher scores indicate greater functional ability in daily activities and therefore a better outcome.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  5. Pediatric Evaluation of Disability Inventory-Computer Adaptive Test Mobility Domain Scaled Score

    Functional mobility will be assessed using the Mobility domain of the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). Scaled scores range from 20 to 80. Higher scores indicate greater mobility-related functional ability and therefore a better outcome.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  6. Pediatric Evaluation of Disability Inventory-Computer Adaptive Test Social/Cognitive Domain Scaled Score

    Social and cognitive functional performance will be assessed using the Social/Cognitive domain of the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). Scaled scores range from 20 to 80. Higher scores indicate greater social/cognitive functional ability and therefore a better outcome.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

  7. Pediatric Evaluation of Disability Inventory-Computer Adaptive Test Responsibility Domain Scaled Score

    Functional responsibility will be assessed using the Responsibility domain of the Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT). Scaled scores range from 20 to 80. Higher scores indicate greater functional responsibility and independence and therefore a better outcome.

    Measured: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2026
  2. Study start15 Sep 2026
  3. Primary completion28 Oct 2026 (estimated)
  4. Study completion28 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1:1 ratio to one of three parallel intervention groups: active transcranial direct current stimulation combined with virtual reality rehabilitation, sham transcranial direct current stimulation combined with the same virtual reality rehabilitation, or conventional physical therapy. Each group will receive 18 treatment sessions over six weeks, with three sessions per week. Outcomes will be assessed at baseline, after nine sessions, and after 18 sessions.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07829796
Sponsor's protocol ID
RCRAHS-ISB/REC/MS-PT/02334
Status last verified
Sep 2026
First submitted
15 Sep 2026
Last updated
23 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared publicly because the study involves a pediatric clinical population and the consent and ethical approval were not designed for unrestricted external sharing of participant-level data. Aggregate and de-identified study results will be reported in the thesis and subsequent publications.

Publications

  • Jung S, Song S, Lee D, Lee K, Lee G. Effects of Kinect Video Game Training on Lower Extremity Motor Function, Balance, and Gait in Adolescents with Spastic Diplegia Cerebral Palsy: A Pilot Randomized Controlled Trial. Dev Neurorehabil. 2021 Apr;24(3):159-165. doi: 10.1080/17518423.2020.1819458. Epub 2020 Sep 27.

    PubMed 32981401
  • Grecco LA, Duarte Nde A, de Mendonca ME, Pasini H, Lima VL, Franco RC, de Oliveira LV, de Carvalho Pde T, Correa JC, Collange NZ, Sampaio LM, Galli M, Fregni F, Oliveira CS. Effect of transcranial direct current stimulation combined with gait and mobility training on functionality in children with cerebral palsy: study protocol for a double-blind randomized controlled clinical trial. BMC Pediatr. 2013 Oct 11;13:168. doi: 10.1186/1471-2431-13-168.

    PubMed 24112817
  • Lazzari RD, Politti F, Belina SF, Collange Grecco LA, Santos CA, Dumont AJL, Lopes JBP, Cimolin V, Galli M, Santos Oliveira C. Effect of Transcranial Direct Current Stimulation Combined With Virtual Reality Training on Balance in Children With Cerebral Palsy: A Randomized, Controlled, Double-Blind, Clinical Trial. J Mot Behav. 2017 May-Jun;49(3):329-336. doi: 10.1080/00222895.2016.1204266. Epub 2016 Sep 20.

    PubMed 27644454
  • Collange Grecco LA, de Almeida Carvalho Duarte N, Mendonca ME, Galli M, Fregni F, Oliveira CS. Effects of anodal transcranial direct current stimulation combined with virtual reality for improving gait in children with spastic diparetic cerebral palsy: a pilot, randomized, controlled, double-blind, clinical trial. Clin Rehabil. 2015 Dec;29(12):1212-23. doi: 10.1177/0269215514566997. Epub 2015 Jan 20.

    PubMed 25604912

Questions about this trial

What is this clinical trial studying?

A study testing Active Transcranial Direct Current Stimulation, Virtual Reality Rehabilitation and Conventional Physical Therapy in people with Spastic Diplegic Cerebral Palsy, run by Riphah International University at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact HASSAN R RAUF, MS PEDIATRIC PHYSICAL THERAPY (+923161504297, hassanrauf507@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

10-Meter Walk Test Self-Selected Walking Velocity (time frame: Baseline (Week 0), after 9 treatment sessions (approximately Week 3), and after 18 treatment sessions (approximately Week 6)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07829796, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in